Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Patients with migraine do not have MRI-visible cortical lesions.
The effect of the interval-between-sessions on prefrontal transcranial direct current stimulation (tDCS) on cognitive outcomes: a systematic review and meta-analysis.
Mycoplasma pneumonia seroposivity in Iranian patients with relapsing-remitting multipl sclerosis: a randomized case-control study.
Relationships between retinal axonal and neuronal measures and global central nervous system pathology in multiple sclerosis.
Interference with RhoA-ROCK Signaling Mechanism in Autoreactive CD4(+) T Cells Enhances the Bioavailability of 1,25-Dihydroxyvitamin D(3) in Experimental Autoimmune Encephalomyelitis.
Laquinimod - New Promising Treatment for Multiple Sclerosis
Gilenya prescribing information
Modulation of nitric oxide synthase by arginase and methylated arginines during the acute phase of experimental multiple sclerosis.
Liposarcoma concurrence in a multiple sclerosis patient treated with interferon-beta 1b.
VLA-4 blockade promotes differential routes into human CNS involving PSGL-1 rolling of T cells and MCAM-adhesion of TH17 cells.
Pharmacokinetic profile of dalfampridine extended release: clinical relevance in patients with MS.
Altered microRNA expression in B lymphocytes in multiple sclerosis: Towards a better understanding of treatment effects.
B-cell depletion in vitro and in vivo with an afucosylated anti-CD19 antibody.
Teva Presents New Data Which Demonstrate Reduction of Injection-Related Adverse Events with the Less Frequent Dosing of Three-times-a-week COPAXONE® (glatiramer acetate injection) 40 mg Compared to Daily COPAXONE® 20 mg
Glatiramer acetate (copaxone) modulates platelet activation and inhibits thrombin-induced calcium influx: possible role of copaxone in targeting platelets during autoimmune neuroinflammation.
Pregnancy level of estrogen attenuates experimental autoimmune encephalomyelitis in both ovariectomized and pregnant C57BL/6 mice through expansion of Treg and Th2 cells.
New data show positive results from Phase 4 study of Avonex Pen for treatment of RRMS patients
Country, Sex, EDSS Change and Therapy Choice Independently Predict Treatment Discontinuation in Multiple Sclerosis and Clinically Isolated Syndrome.
Calcitriol Modulates the CD46 Pathway in T Cells.
Plasma Exchange in a Patient with Tumefactive, Corticosteroid-Resistant Multiple Sclerosis.
Amyloid precursor protein at node of Ranvier modulates nodal formation.
Long term lymphocyte reconstitution after alemtuzumab treatment of multiple sclerosis.
First NW patient to receive OHSU/VAMC-invented MS drug
Editorial for JNV issue on PML.
Long-term effects of dalfampridine in patients with multiple sclerosis.

Pages